Total Non-Current Liabilities

$39.64B

Quarterly · Period ending: Jun 30, 2026 · USD

Latest reported$17.45Bperiod endingDec 31, 2025

ABT FY Total Non-Current Liabilities ($809.20M → $17.45B)

Annual total non-current liabilities

High-resolution chart · PNG

ABT total non-current liabilities history

Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Abbott Laboratories Total Non-Current Liabilities — Annual fiscal periods (USD)
Period ending	Total Non-Current Liabilities (USD)
Dec 31, 2025	17,446,000,000
Dec 31, 2024	19,356,000,000
Dec 31, 2023	20,546,000,000
Dec 31, 2022	22,044,000,000
Dec 31, 2021	26,067,000,000
Dec 31, 2020	27,638,000,000
Dec 31, 2019	25,723,000,000
Dec 31, 2018	27,439,000,000
Dec 31, 2017	36,240,000,000
Dec 31, 2016	27,634,000,000
Dec 31, 2015	13,489,000,000
Dec 31, 2014	11,685,000,000
Dec 31, 2013	8,179,000,000
Dec 31, 2012	27,142,000,000
Dec 31, 2011	20,270,520,000
Dec 31, 2010	20,546,287,000
Dec 31, 2009	16,344,738,000
Dec 31, 2008	13,347,745,000
Dec 31, 2007	12,832,106,000
Dec 31, 2006	10,172,791,000
Dec 31, 2005	7,310,418,000
Dec 31, 2004	7,616,067,000
Dec 31, 2003	6,003,549,000
Dec 31, 2002	6,592,347,000
Dec 31, 2001	6,310,174,000
Dec 31, 2000	2,414,808,000
Dec 31, 1999	2,526,738,000
Dec 31, 1998	2,540,426,000
Dec 31, 1997	2,027,923,000
Dec 31, 1996	1,961,701,000
Dec 31, 1995	1,225,419,000
Dec 31, 1994	998,458,000
Dec 31, 1993	918,707,000
Dec 31, 1992	811,100,000
Dec 31, 1991	823,000,000
Dec 31, 1990	728,500,000
Dec 31, 1989	741,600,000
Dec 31, 1988	920,800,000
Dec 31, 1987	805,400,000
Dec 31, 1986	783,200,000
Dec 31, 1985	809,200,000